NOVIMMUNE Trademark

Trademark Overview

On Tuesday, February 1, 2000, a trademark application was filed for NOVIMMUNE with the United States Patent and Trademark Office. The USPTO has given the NOVIMMUNE trademark a serial number of 75907462. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, July 16, 2025. This trademark is owned by NovImmune SA. The NOVIMMUNE trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations used in humans and animals for the treatment of autoimmune diseases, inflammation and transplantation, namely, superantigens, small molecular weight compounds, polypeptides and monoclonal antibodies; pharmaceutical and veterinary preparations for the treatment of autoimmune diseases, inflammation and for use during transplantation, including diabetes, multiple sclerosis, rheumatoid arthritis and lupus, and for immuno-modulation, namely, immuno-suppression; pharmaceutical and veterinary preparations for the modulation and control of T lymphocyte activation; [ superantigens; superantigens encoded by human endogenous retroviruses; superantigens responsible for T cell activation in autoimmune diseases; regulatory factors responsible for the control of expression of MHC class II molecules, ] regulatory factors that are directly involved in the control of T lymphocyte activation; polypeptides to treat diseases; vaccines; monoclonal antibodies to treat diseases

Chemicals for use in the manufacture of pharmaceutical preparations used in humans and animals for the treatment of autoimmune diseases, inflammation and transplantation, including [ superantigens, ] small molecular weight compounds, polypeptides and monoclonal antibodies

legal services; scientific research; chemical research; consulting in the pharmaceutical and biomedical fields
novimmune

General Information

Serial Number75907462
Word MarkNOVIMMUNE
Filing DateTuesday, February 1, 2000
Status800 - REGISTERED AND RENEWED
Status DateWednesday, July 16, 2025
Registration Number2873048
Registration DateTuesday, August 17, 2004
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 24, 2004

Trademark Statements

Goods and ServicesPharmaceutical preparations used in humans and animals for the treatment of autoimmune diseases, inflammation and transplantation, namely, superantigens, small molecular weight compounds, polypeptides and monoclonal antibodies; pharmaceutical and veterinary preparations for the treatment of autoimmune diseases, inflammation and for use during transplantation, including diabetes, multiple sclerosis, rheumatoid arthritis and lupus, and for immuno-modulation, namely, immuno-suppression; pharmaceutical and veterinary preparations for the modulation and control of T lymphocyte activation; [ superantigens; superantigens encoded by human endogenous retroviruses; superantigens responsible for T cell activation in autoimmune diseases; regulatory factors responsible for the control of expression of MHC class II molecules, ] regulatory factors that are directly involved in the control of T lymphocyte activation; polypeptides to treat diseases; vaccines; monoclonal antibodies to treat diseases
Goods and ServicesChemicals for use in the manufacture of pharmaceutical preparations used in humans and animals for the treatment of autoimmune diseases, inflammation and transplantation, including [ superantigens, ] small molecular weight compounds, polypeptides and monoclonal antibodies
Goods and Serviceslegal services; scientific research; chemical research; consulting in the pharmaceutical and biomedical fields

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, May 4, 2000
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 4, 2000
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 4, 2000
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovImmune SA
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGeneva 1228
CH
Party NameNovImmune SA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address1207 Geneva
CH
Party NameNovImmune SA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address1207 Geneva
CH

Trademark Events

Event DateEvent Description
Wednesday, December 27, 2000CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, October 29, 1961EX PARTE APPEAL-INSTITUTED
Wednesday, June 21, 2000ASSIGNED TO EXAMINER
Tuesday, June 27, 2000NON-FINAL ACTION MAILED
Friday, April 6, 2001FINAL REFUSAL MAILED
Monday, October 29, 2001JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, November 13, 2001CONTINUATION OF FINAL REFUSAL MAILED
Wednesday, June 19, 2002EXAMINERS STATEMENT MAILED
Thursday, October 24, 2002JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, October 24, 2002JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, January 6, 2003PAPER RECEIVED
Monday, January 6, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 27, 2003ASSIGNED TO EXAMINER
Tuesday, February 25, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 11, 2003PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, April 14, 2003NON-FINAL ACTION MAILED
Tuesday, October 14, 2003PAPER RECEIVED
Tuesday, October 14, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 13, 2003CASE FILE IN TICRS
Friday, December 5, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 4, 2004NOTICE OF PUBLICATION
Tuesday, February 24, 2004PUBLISHED FOR OPPOSITION
Tuesday, May 18, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 1, 2004PAPER RECEIVED
Wednesday, June 30, 2004NOTICE OF ALLOWANCE CANCELLED
Wednesday, June 30, 2004Sec. 1(B) CLAIM DELETED
Tuesday, August 17, 2004REGISTERED-PRINCIPAL REGISTER
Tuesday, August 24, 2004EXPARTE APPEAL TERMINATED
Tuesday, August 17, 2010TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 17, 2010APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 17, 2010TEAS SECTION 8 RECEIVED
Monday, August 23, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 10, 2010POST REGISTRATION ACTION MAILED - SEC. 8
Thursday, March 10, 2011TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, April 22, 2011REGISTERED - SEC. 8 (6-YR) FILED
Friday, April 22, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, August 18, 2014TEAS SECTION 8 & 9 RECEIVED
Wednesday, September 3, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 4, 2014POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Wednesday, February 18, 2015TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, July 27, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, July 27, 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, July 27, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, September 25, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 25, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 20, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 20, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 20, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 20, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 20, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, April 20, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 20, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 17, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, February 14, 2025TEAS SECTION 8 & 9 RECEIVED
Monday, May 26, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, May 26, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 26, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 26, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, May 26, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 15, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 16, 2025REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Wednesday, July 16, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, July 16, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Related Keywords

novimmune diseases superantigens pharmaceutical autoimmune preparations monoclonal polypeptides activation transplantation inflammation